Abstract
This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform.
Table of Contents
1 EXECUTIVE SUMMARY
- Scope and Methodology
- Scope and Segmentation of the Research Service
- Research Methodology
- Overview of Metabolomics
- The Road to Metabolomics
- Technology Platform for Metabolomics
- Applications of Metabolomics
2 ASSESSMENT OF ENABLING TECHNOLOGIES--METABOLOMICS
- Noteworthy Innovations in Companies and Universities
- Tracer-Based Metabolomics Platform
- Biospectroscopy-Based Metabolomics
- Chenomx NMR Suite for Analysis of NMR spectra
- Pathway Studio Software for Data Analysis
- Metabolomics--Technology Improvements
- Software Implemented to Manage Data in Metabolomics Studies
- Integrated Metabolomics Platform Aids in Biomarker Discovery
- Mass Spectrometry for Omics Studies
- The KnowItAll Informatics System for Metabolic Studies
- AutoNano System for Mass Spectrometry Analysis
- NMR Chip for Remote Detection of NMR
- Drivers and Challenges
- Drivers
- Challenges
3 ASSESSMENT OF METABOLOMICS APPLICATIONS
- Noteworthy Innovations in Companies and Universities
- Researchers Hone in on Metabolites to Predict Drug Efficiency
- Metabolomic Biomarker Discovery Platform
- Highly Integrated State-of-the-Art NMR Spectrometer for Academic and Industry Applications
- Metabolic Profiling to Determine Human Embryo Viability
- Stem Cells and Metabolomics--New Avenues in Biomarker Discovery
- Application-Oriented Version of HPLC
- Oxidative Stress Markers in Cardiovascular Diseases
- Drivers and Challenges
- Drivers
- Challenges
4 STRATEGIC EVALUATION OF THE COMPETITIVE ENVIRONMENT
- AHP--Prioritization of Metabolomics Technologies--Criteria
- Definition of Criteria
- Snapshot of Assessment Criteria Used for Evaluation
- AHP--Prioritization of Metabolomics Technologies--Computation and Analyst
Insights
- AHP Process and Computation for Goal Node and Level 0 Criteria
- AHP Process and Computation for Goal Node and Level 1 Criteria
- Final Priorities and Analyst Insights
5 PATENTS AND DATABASE OF KEY INDUSTRY PARTICIPANTS
- Patents
- Industry Patents
- Academic Patents
- Key Participants
- Companies
- Universities
6 DECISION SUPPORT DATABASE
- Database Tables
- Global R&D Investment for Biotechnology (2002 to 2012)
- Percent Government R&D Investment in Biotechnology (2002 to 2012)
- Global Pharmaceutical R&D Expenditure (2002 to 2012)
- Global Percentage Pharmaceutical R&D Expenditure (2002 to 2012)
